| D02248 | |
| D number | D02248 |
| Classification | Drug |
| Name | Levomepromazine maleate (JP17/USAN); Hirnamin (TN) |
| Component | - |
| Formula | C19H24N2OS. C4H4O4 |
| Exact mass | 444.1719 |
| Mol weight | 444.5438 |
| Structural formula |  |
| Sequence | - |
| Sequence type | - |
| Source | - |
| Upper DGroup | Cardiovascular agent DG01466 Adrenergic receptor antagonist DG01465 alpha-Adrenergic receptor antagonist DG01457 alpha1-Adrenergic receptor antagonist DG01460 alpha2-Adrenergic receptor antagonist Neuropsychiatric agent DG01905 Phenothiazine antipsychotics DG01478 Dopamine antagonist DG01474 Dopamine D2-receptor antagonist Cyp substrate DG01644 CYP2D6 substrate Cyp inhibitor DG01645 CYP2D6 inhibitor |
| Remark | Therapeutic category: 1172 ATC code: N05AA02 Chemical group: DG00868 |
| Activity | - |
| Disease | - |
| Comment | Phenothiazine derivative |
| Target | DRD2 [HSA:1813] [KO:K04145] |
| Metabolism | - |
| Interaction | |
| Other DBs | CAS: 7104-38-3 PubChem: 7849307 ChEMBL: CHEMBL1725730 LigandBox: D02248 NIKKAJI: J231.544K |
| KCF data | - |